drugset / Trial / NCT01946048

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy

NCT01946048

Phase 1 Unknown 10 enrolled Hebei Medical University
NaSingle-groupOpen-labelTreatment

Summary

The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy .

Timeline

Start
2013-10
Primary completion
2013-10
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1.5e+08 cells Other
Subject mesenchymal stem cells Cell therapy 2.5e+08 cells Other

Indications